Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

iwNHL 2019 Session V: Novel Lymphoma Targets/Agents

Immunomodulatory drugs – where are we going?

Thomas Witzig